Alliance4Life Secured Funding for the Next Three Years
Alliance4Life’s new project A4L_ACTIONS, submitted under the Horizon 2020 programme, has been selected for funding. Alliance4Life’s next three years will thus be co-financed with a grant of 2 mil. EUR, which will allow a number of already successfully piloted good practices to be put into action.
The Alliance4Life started as a project initiated by CEITEC Masaryk University with the clear mission to help close the innovation gap between west and east Europe. Despite considerable investments from the European Structural and Investment Funds (ESIF), there are still large differences in Research and Innovation (R&I) performance between various countries in Europe. The R&I gap in the health sector has a profound effect on the distribution of research funding from the EU Framework Programmes, and therefore hinders the overall impact of R&I results on the quality of health and life of European citizens.
It was the activities of Alliance4Life that served as a starting point for the development strategies of the participating institutions for all seven target groups – science evaluation, ethics and integrity, human resources and mobility, grants and funding, core facilities, knowledge and technology transfer, and science communication. The project enabled the members to gather for joint trainings and to develop best practice inventory, representing an enormous value for the members.
A4L_ACTIONS is the continuation of the successfully implemented Alliance4Life project. Its mission is to support and strengthen European research excellence and the impact of scientific research on society, human health, and quality of life. The 10 founding members formalized the alliance as a permanent structure in October 2019 in Vilnius through the signing of the Memorandum of Understanding, and continued with their collaboration even during the difficult year 2020. Two new member institutions from Bulgaria and Romania were invited to join the A4L_ACTIONS project, which will start in May 2021.
Masaryk University (CEITEC MU – Central European Institute of Technology), Czech Republic
International Clinical Research Center of St. Anne’s University Hospital Brno (FNUSA-ICRC), Czech Republic
Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS), Slovakia
Medical University of Łodz (MUL), Poland
University of Zagreb School of Medicine (UZSM), Croatia
University of Tartu (TU), Estonia
Vilnius University – Faculty of Medicine (VU), Lithuania
Latvian Institute of Organic Synthesis (LIOS), Latvia
University of Ljubljana (UL), Slovenia
Semmelweis University (SU), Hungary
Medical University Sofia (MUS), Bulgaria
Carol Davila University of Medicine and Pharmacy Bucharest (UMFCD), Romania